Europe Blood Screening Market Size & Share, Sector / Industry Report & Analysis, 2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Europe Blood Screening Market


The Europe Blood Screening market size is projected to reach US$ 1264.3 million by 2026, from US$ 810.13 million in 2020, at a CAGR of 7.7% during 2021-2026. Rising number of blood transfusion procedures is expected to be the major factor boosting the market growth. Rise in the number of complex surgeries performed, such as chemotherapy, heart surgery, and organ transplant, which require a large amount of blood samples is also likely to have a positive impact on the market.

Moreover, increasing awareness about safe blood transfusion and rising incidence of infectious diseases are projected to augment the market development in the coming years. Stringent government regulations regarding the screening of all donors and donated blood for patient safety are anticipated to further propel the market growth.

Such guidelines regarding the transfusion services provide a regulatory framework for the manufacturers of blood transfusion reagents. European countries have mandated the blood screening for HIV, HBV, HCV, parvovirus 19, and other viruses. The blood transfusion services in Germany are regulated by the International Red Cross, the Code of International Society of Blood Transfusion, and the German Transfusion Act.

In France, the French Blood Establishment (EFS) regulates the collection, preparation, testing, and distribution of labile blood products. In Italy, the National Blood Centre (NBC), a division of health ministry, is responsible for the coordination of technical and scientific control of the blood system.

Market Segmentation, Outlook & Viewpoint: Europe Blood Screening Market

Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Nucleic Acid Amplification Test (NAT)
  
Enzyme-Linked Immunosorbent Assay (ELISA)
  
Chemiluminescence Immunoassay (CLIA)
  
Next-Generation Sequencing (NGS)
  
Western Blotting

Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Reagents
  
Instruments

Key Players, Recent Developments & Regional Insights: Europe Blood Screening Market

Based on product, the Europe blood screening market is segmented into reagents and instruments. Reagents segment led the market in 2017. Reagents are necessary for ELISA, western blotting, and NAT testing. Rising adoption of these tests contributed to the high demand for reagents. Instruments are expected to witness lesser demand than reagents as they are one-time investment for blood testing due to their high costs and long shelf-life.

Regional Insights

Geographically, the market has been classified into U.K., Germany, France, Italy, and Spain. In 2017, Germany held the largest market share and is expected to retain its position throughout the forecast period. The regional market is expected to grow due to a rise in awareness about blood donation.

According to the WHO, blood donation increased from 3.4% in 2008 to 3.6% in 2010. Around 2 million people donate blood regularly in Germany. In France, NAT has been voluntarily implemented to increase the safety specific to non-enveloped viruses, such as Hepatitis A Virus (HAV) and Parvovirus B19 (B19V).

Europe Blood Screening Market Share Insights

Some of the major companies in the market are Roche Diagnostics; Bio-Rad Laboratories, Inc.; Siemens Healthcare GMBH; Grifols, S.A.; Becton, Dickinson and Company; Agilent Technologies; Thermo Fisher Scientific, Inc.; and Danaher Corp. Most of the manufacturers focus on new technology launch and M&A activities for business expansion.

For instance, Grifols acquired Hologics unit, which is engaged in manufacturing and R&D of assays and instruments based on NAT technology for donor screening. The sales of Procleix NAT Solutions from this acquisition became the leading source of revenue for the diagnostic division.

Key Insights Covered: Europe Blood Screening Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Europe Blood Screening industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Europe Blood Screening industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Europe Blood Screening industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Europe Blood Screening industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Europe Blood Screening industry.

Research Methodology: Europe Blood Screening Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other